These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10406354)

  • 41. Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.
    Monteleone G; Pallone F
    N Engl J Med; 2015 Jun; 372(25):2461. PubMed ID: 26083213
    [No Abstract]   [Full Text] [Related]  

  • 42. Top-down in the Long Term in Crohn's Disease.
    Boyapati RK; Ho GT; Satsangi J
    J Crohns Colitis; 2018 Apr; 12(5):513-514. PubMed ID: 29548025
    [No Abstract]   [Full Text] [Related]  

  • 43. Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?
    Danese S; Fiorino G; Peyrin-Biroulet L
    Gastroenterology; 2015 Oct; 149(4):1121-3. PubMed ID: 26319033
    [No Abstract]   [Full Text] [Related]  

  • 44. Therapy: Oral SMAD7 antisense oligonucleotide proves effective for Crohn's disease.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2015 May; 12(5):251. PubMed ID: 25824998
    [No Abstract]   [Full Text] [Related]  

  • 45. Steroid dependency in Crohn's disease.
    Reinisch W; Vogelsang H
    Gastroenterology; 2002 Jul; 123(1):393-5; author reply 395. PubMed ID: 12105883
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term control of laryngeal plasma cell mucositis with systemic immunosuppression.
    Triplett J; Hee G; McLean-Tooke A; Lucas M
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29930164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized controlled trial of two hepatitis A vaccine doses among adolescents with juvenile idiopathic arthritis and Crohn's disease on immunosuppressive therapy: a pilot study.
    Githumbi R; Kuhn S; Osiowy C; Day J; deBruyn JCC; Fritzler MJ; Johnson NA; Vanderkooi O; Schmeling H
    J Travel Med; 2024 Jun; 31(4):. PubMed ID: 38652172
    [No Abstract]   [Full Text] [Related]  

  • 48. Successful handling of autoimmunity in X-linked thrombocytopenia (XLT) using mycophenolate mofetil.
    Casimiro A; Almeida T; Freitas O; Cordeiro AI; Neves C; Neves JF
    Pediatr Blood Cancer; 2012 Nov; 59(5):961. PubMed ID: 22692965
    [No Abstract]   [Full Text] [Related]  

  • 49. Crohn's disease and IL-10 therapy: promise regained.
    de Villiers WJ
    Inflamm Bowel Dis; 2003 May; 9(3):210-1. PubMed ID: 12797349
    [No Abstract]   [Full Text] [Related]  

  • 50. Reply: To PMID 25785968.
    Monteleone G; Pallone F
    Gastroenterology; 2015 Oct; 149(4):1123. PubMed ID: 26319031
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical trials review: vasculitis.
    Ledford DK
    Curr Rheumatol Rep; 2000 Oct; 2(5):365-8. PubMed ID: 11123084
    [No Abstract]   [Full Text] [Related]  

  • 52. The TREAT Registry: Evolution of Knowledge From 1999 to 2017: Lessons Learned.
    Lichtenstein GR
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1319-1321. PubMed ID: 28554680
    [No Abstract]   [Full Text] [Related]  

  • 53. Year 1979: Results from the pharmacological treatment of Crohn's disease.
    Gomollón F; Marín-Jiménez I
    Gastroenterol Hepatol; 2020; 43(7):371-372. PubMed ID: 32713496
    [No Abstract]   [Full Text] [Related]  

  • 54. Mycophenolate mofetil in patients with Crohn's disease.
    Fickert P; Hinterleitner TA; Wenzl HH; Aichbichler BW; Petritsch W
    Am J Gastroenterol; 1998 Dec; 93(12):2529-32. PubMed ID: 9860419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mycophenolate mofetil in Crohn's disease.
    Rampton DS; Neurath MF; Almer S; D'Haens G; Petritsch W; Stange EF
    Lancet; 2000 Jul; 356(9224):163-4. PubMed ID: 10963270
    [No Abstract]   [Full Text] [Related]  

  • 56. Mycophenolate mofetil, Crohn's disease, measles?
    Altschuler EL
    Am J Gastroenterol; 2000 Feb; 95(2):550-1. PubMed ID: 10685769
    [No Abstract]   [Full Text] [Related]  

  • 57. Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.
    Jones EA
    Hepatology; 2002 Feb; 35(2):258-62. PubMed ID: 11826397
    [No Abstract]   [Full Text] [Related]  

  • 58. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
    Assmann T; Ruzicka T
    Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
    [No Abstract]   [Full Text] [Related]  

  • 59. Mycophenolate mofetil for Crohn's disease?
    Lowry PW; Sandborn WJ; Lipsky JJ
    Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.